Y-MABS THERAPEUTICS INC

CUSIP: 984241109 Class: Common Stock

Soleus Capital Management, L.P.'s Holding History (CIK: 0001802630)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 349,982 Value ($000) $1,578 Avg Close — Range —
Q1 2025
Shares 349,982 Value ($000) $1,550 Avg Close — Range —
Q4 2024
Shares 349,982 Value ($000) $2,740 Avg Close — Range —
Q3 2024
Shares 399,982 Value ($000) $5,260 Avg Close — Range —
Q2 2024
Shares 647,982 Value ($000) $7,828 Avg Close — Range —
Q1 2024
Shares 570,982 Value ($000) $9,284 Avg Close — Range —
Q4 2023
Shares 157,182 Value ($000) $1,072 Avg Close — Range —
Q3 2023
Shares 157,182 Value ($000) $857 Avg Close — Range —
Q2 2023
Shares 157,182 Value ($000) $1,067 Avg Close — Range —
Q1 2023
Shares 87,182 Value ($000) $437 Avg Close — Range —
Q4 2022
Shares 87,182 Value ($000) $425 Avg Close — Range —
Q3 2022
Shares 87,182 Value ($000) $1,257 Avg Close — Range —
Q2 2022
Shares 136,182 Value ($000) $2,060 Avg Close — Range —
Q1 2022
Shares 238,982 Value ($000) $2,839 Avg Close — Range —
Q4 2021
Shares 310,494 Value ($000) $5,033 Avg Close — Range —
Q3 2021
Shares 265,700 Value ($000) $7,583 Avg Close — Range —
Q2 2021
Shares 144,300 Value ($000) $4,877 Avg Close — Range —